A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 25, 2018
Source ID
10.1093/cid/ciy185

Entities

People

  • Ashraf S. Ibrahim
  • Clint S. Schmidt
  • Elizabeth A Demontigny
  • Erica Marchus
  • Florian Schodel
  • Jack D Sobel
  • Jesse Hoeg
  • John E. Edwards Jr.
  • John P. Hennessey Jr.
  • Keila Hoover
  • Lance Edwards
  • M. Timothy Cooke
  • Mark Jacobs
  • Mary Lizakowski
  • Michael Augenbraun
  • Michael Drusano
  • Michael M. Schwartz
  • Michael R. Yeaman
  • Paul Nyirjesy
  • Scott G. Filler
  • Steven Sussman
  • Tuomas Holmberg

Organizations

  • Drexel University
  • National Institutes of Health
  • United States Department of Defense
  • University of California, Los Angeles
  • Wayne State University

Tags

Technology Areas

  • Biotechnology